Swedbank’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,722
Closed -$348K 741
2022
Q3
$348K Sell
13,722
-2,991
-18% -$105K ﹤0.01% 702
2022
Q2
$555K Sell
16,713
-65,350
-80% -$2.78M ﹤0.01% 683
2022
Q1
$5.92M Buy
82,063
+126
+0.2% +$9.08K 0.01% 524
2021
Q4
$7.73M Sell
81,937
-1,307
-2% -$156K 0.01% 507
2021
Q3
$10.6M Buy
83,244
+3,010
+4% +$438K 0.02% 458
2021
Q2
$13.3M Buy
80,234
+17,690
+28% +$2.87M 0.03% 425
2021
Q1
$11.4M Buy
+62,544
New +$14.5M 0.02% 437

Other funds holding TDOC

Swedbank's TDOC Position: Q4 2022 in Review

Swedbank sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 13,722 shares — an estimated $348K sold.

Swedbank first reported a position in TDOC in Q1 2021 and held it in 7 quarters. The position peaked at $13.3M in Q2 2021. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Swedbank reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Swedbank sold 13,722 Teladoc Health shares in Q4 2022, an estimated $348K.
  • Swedbank first reported a position in Teladoc Health in Q1 2021 and held it in 7 quarters.
  • Swedbank's Teladoc Health position peaked at $13.3M in Q2 2021.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Swedbank's 13F filing for Q4 2022, filed 6 Dec 2024.